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This Research Topic, Ion Channels and Mental Illness: Exploring etiology and pathophysiology in
major psychiatric disorders, presents three original research manuscripts and five literature reviews
that advance our understanding of the role of ion channels in the etiology and pathogenesis of
psychiatric disease.
Gilling et al. (2013) present their original findings of a novel de novo truncating translocation
of KCNQ3 in one subject with autism and of a very rare nucleotide substitution (rs74582884) in
KCNQ3 in three new subjects with autism. The substitution was previously reported in patients
with forms of epilepsy. Heterologous expression of mutant channels in Xenopus laevis oocytes
demonstrated reduced current through the Kv7.3/Kv7.5 channel complex relative to wild type. They
suggest that functional impairment of the Kv7.3/Kv7.5 channel complex may confer susceptibility
to several neuropsychiatric disorders.
Judy et al. (2013) examine three bipolar disorder (BP) genome-wide association studies (GWAS)
datasets for evidence of two-way interactions between ANK3 SNPs and SNPs in 14 identified ANK3
interactor proteins. ANK3 is an adaptor protein that, through interactions with KCNQ2/KCNQ3
channel complexes, directs channel localization in neuronal axon initial segment and contributes
to stabilization of the neuronal resting potential. In the discovery sample, they found 31 signifi-
cant interactions between 16 different ANK3 SNPs and two SNPs from KNQ2, which encodes a
voltage-gated potassium channel. Twenty-eight of these interactions were also significant in the
first replication GWAS. While none were significant in the second replication sample, the two dis-
covery KCNQ2 SNPs showed significant interactions with five different ANK3 SNPs, supporting
potential allelic heterogeneity.
Tomita et al. (2013) present their original work comparing human brain expression of 445 G-
protein linked signaling system (GPLS) gene transcripts in selected brain regions in subjects with
BP, major depressive disorder (MDD) and controls. Their findings suggest enhanced expression
of several GPLS transcripts in BP and blunted expression in MDD, particularly in the anterior
cingulate cortex. Orphan G-proteins, GPRC5B, and GPR37 were most consistently differentially-
expressed, representing novel candidate susceptibility genes. GPR37 likely facilitate dopamine neu-
rotransmission, while GPRC5B may be involved in spontaneous locomotor activity and response
to new environments.
Schmunk and Gargus (2013) review the role of channelopathies in the pathogeneses of ASDs.
They begin with an excellent overview of ion channel neurophysiology and then focus on sum-
marizing known ion channel gene defects found in ASD. While many of the identified channel
mutations do not neatly segregate with ASD within families, a number of susceptibility alle-
les have been strongly implicated in family-based studies. More recently, deep resequencing has
identified potentially causal rare variants in ASD, including in CACNA1F, SCN1A, and SCN7A.
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The authors make a case that the collection of identified vari-
ants implicate calcium signaling in the pathogenesis and potential
treatment targets in ASD.
O’Brien andMeisler (2013) provide a compelling review of the
evidence for SCN8A mutations in sporadic human neuropsychi-
atric disease. They first describe the unique functional properties
of the encoded protein, Nav1.6, relating those to the functional
consequences of mutations therein, as observed in in vivo mod-
els and in human mutations. They describe more than 10 de
novo human mutations in patients with epileptic encephalopa-
thy and intellectual disability. Though functional data on these
mutations is currently limited, it suggests gain-of-function muta-
tions are associated with seizure disorders while loss-of-function
predisposes to intellectual disability. With the advent of next-
generation sequencing technology (NGS), identification of addi-
tional mutations will enhance our understanding of SCN8A
mutations in the differential pathogenesis of epilepsy, movement
disorders and cognitive impairment.
Judy and Zandi (2013) review recent evidence in genetic and
expression studies supporting a role for voltage-gated potassium
channels in the etiology of BP. They describe extant GWAS evi-
dence for common genetic associations, noting the importance
of large studies and meta-analyses in the detection of the mod-
est effects conferred by common variants. The most consistent
findings provided by GWAS to date have been for SNPs in ANK3
and several calcium channel genes; pathways-based analyses of
GWAS data have converged on ion channel gene sets, more gen-
erally. The authors conclude that both statistical evidence and
biological plausibility favor the involvement of ion channel genes
in BP etiology.
Imbrici et al. (2013) review recent studies that impli-
cate calcium, sodium and potassium channel genes in several
neuropsychiatric disorders and describe promising pharmaco-
logic strategies for targeting ion channels. Importantly, they note
that several commercially-available psychiatric medications bind
directly to and alter ion channel functioning which, in turn,
alters extracellular concentrations of several neurotransmitters
that have long been implicated in the pathophysiology of dis-
ease. The authors highlight several channel subtypes that have
emerged as critical targets for drug development.
Finally, Martinez-Martinez et al. (2013) provide an overview
of neuromuscular channelopathies as an exemplar of cen-
tral nervous system (CNS) channelopathies more generally.
They review the evidence supporting a role for channel
and receptor autoantibodies in neuropsychiatric disease. They
also describe known ion channel autoantibody targets in the
brain and the diseases related to them. While most of these
conditions are encephalitides with some psychiatric mani-
festations, the authors report findings supporting a poten-
tial role of immune mechanisms in patients with exclusively
neuropsychiatric disease.
Most authors aptly note that progress in neuropsychiatric dis-
ease genetics has been stalled by the complex genetic influences
involved. General consensus in the field is that this complexity
is marked by extensive interactions among many genetic vari-
ants within a given affected subject. That said, evidence for causal
effects of rare and de novo mutations is also mounting with the
application of next-generation sequencing (NGS) technologies.
It will be interesting to see how our understanding of disease
architecture may shift as we move from an era dominated by
GWAS to one marked by widespread accessibility of genome-
scale NGS. Whereas sequencing was formerly limited to exam-
ination of subjects with severe, syndromic or otherwise readily
identifiable phenotypes, the dropping cost of NGS now permits
broader application. Of course, this shift in technological capac-
ity will require computational and analytic strategies appropriate
to the task. Otherwise, we may miss out on the insights NGS has
to offer us. For example, it will be important that our methods
are both robust under and able to distinguish between polygenic,
interacting and heterogeneous architectures (see Thornton-Wells
et al., 2004). This may be particularly true in seeking to eluci-
date the role of ion channel genes in neuropsychiatric disease
susceptibility.
Ion channel genes are one of the largest and most function-
ally diverse gene sets in the human genome. Their structural
diversity allows exceptional fine-tuning of cellular functioning,
perhaps most evident in the enormous functional diversity of
neurons. While channel genes are characterized by strong evolu-
tionary conservation, thousands of variants have been identified
as causativemutations in human disease (e.g., cystic fibrosis, mul-
tiple forms of epilepsy, familial migraine, spinocerebellar ataxias,
to name but a few). These known channelopathies likely repre-
sent low-hanging fruit as most are especially severe with readily
characterizable phenotypes. That said, GWAS and NGS studies
in neuropsychiatric disorders are beginning to uncover channel
variants that may confer disease susceptibility. Given their role
in mediating highly-specialized neuronal functioning, and in dif-
ferentiating function across diverse brain systems, this is not sur-
prising. However, these identified variants are likely to be just the
tip of the iceberg. For these more “subtle” and late-onset pheno-
types, we should expect a much greater burden (and diversity)
of mutations to be at play. While the more circumscribed set of
mutations mediating severe syndromic and early-onset diseases
are more amenable to detection by genetic approaches, the larger
mutational targetmediating risk for neuropsychiatric phenotypes
will requiremethods that are not limited by architectural assump-
tions or by parametric methods. I suspect there are a great many
channelopathies yet to be discovered.
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